ArticleThe journal of prevention of Alzheimer's disease2026

Estimating the eligible population for amyloid-targeting monoclonal antibody therapy in memory clinics: Application to lecanemab in France.

Lisa Le Scouarnec et al.PubMed ↗Publisher ↗

No numbers read from the abstract.